Extracellular Vesicles Derived From Neural Stem Cells, Astrocytes, and Microglia as Therapeutics for Easing...

Area of Science:

• Neuroscience
• Regenerative Medicine
• Biotechnology

Background:

• Extracellular vesicles (EVs) from neural stem cells (NSCs), astrocytes, and microglia show neuroregenerative potential.
• Traumatic brain injury (TBI) is a significant cause of neurological damage, necessitating novel therapeutic strategies.
• Current research focuses on the therapeutic efficacy of NSC-EVs, ADEVs, and MDEVs in TBI models.

Approach:

• This review synthesizes findings on the neuroprotective effects and functional recovery mediated by NSC-EVs and ADEVs in TBI.
• It examines the potential of primed EVs (using growth factors or injury extracts) for enhanced therapeutic benefits.
• The review also addresses the limited and sometimes contradictory findings regarding microglial-derived EVs (MDEVs) in TBI.

Key Points:

• NSC-EV and ADEV therapy demonstrates neuroprotection and improves motor/cognitive function post-TBI.
• Priming parental cells enhances the therapeutic benefits of NSC-EVs and ADEVs.
• Therapeutic effects of naive MDEVs in TBI remain largely untested, while activated MDEVs show mixed results.

Conclusions:

• EV therapy for TBI, including NSC-EVs, ADEVs, and MDEVs, requires further rigorous preclinical investigation before clinical translation.
• Key areas for future research include evaluating long-term efficacy against neuroinflammation and cognitive deficits, characterizing EV cargo, optimizing administration routes, and developing clinical-grade EV isolation methods.
• While NSC-EVs and ADEVs hold promise for mitigating TBI-induced dysfunction, extensive validation is essential.